
The ₹138.87 crore Hexagon Nutrition IPO is in its final day of subscription today, June 9, 2026. The public issue is being offered in a price band of ₹42 to ₹45 per share. As of 11:00 AM on the third day of bidding, the IPO had been subscribed 10.98 times.
Investors can bid for the issue until the close of subscription today. The basis of allotment is expected to be finalised on June 10, while the shares are likely to be listed on the BSE and NSE on June 12, 2026.
Explore other Upcoming IPOs on BSE and NSE.
The expected IPO schedule is as follows:
|
Event |
Tentative Date |
|
IPO Opens |
June 5, 2026 |
|
IPO Closes |
June 9, 2026 |
|
Basis of Allotment |
June 10, 2026 |
|
Initiation of Refund |
June 11, 2026 |
|
Credit of Shares to Demat Account |
June 11, 2026 |
|
Listing on BSE and NSE |
June 12, 2026 |
Note - The allotment and listing dates are tentative and may be revised
[June 9, 2026, 11:00 AM]
|
Category |
Subscription (x) |
|
Qualified Institutional Buyers (QIBs) |
0.19 |
|
Non-Institutional Investors (NIIs) |
24.12 |
|
Retail Individual Investors (RIIs) |
11.52 |
|
Total |
10.98 |
Founded in 1993, Hexagon Nutrition Ltd. is a research-driven nutrition company engaged in the development and manufacture of therapeutic nutrition products, micronutrient premixes, wellness solutions, and ready-to-eat food products. Its portfolio spans clinical nutrition and branded wellness products for consumers (B2C), premix solutions for businesses (B2B2C), and ready-to-use foods (RUFs) and micronutrient powders (MNPs).
Financially, the company reported revenue from operations of ₹324.9 crore and a net profit of ₹24.3 crore in FY25, compared with ₹297.7 crore and ₹12.2 crore, respectively, in FY24. For the nine months ended December 31, 2025, Hexagon Nutrition posted revenue of ₹267.5 crore and a profit after tax of ₹27.03 crore.
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here.